Dr. Janelle Thompson

Japanese researchers initiated Phase I human trials of a tooth-regrowing drug, TRG-035, at Kyoto University Hospital in October 2024, targeting USAG-1 protein inhibition. With 30 participants, the trials aim for commercial readiness by 2030. While promising, experts caution that significant challenges remain before widespread availability.

KEY POINTS: According to a 2024 review in PMC, young blood has been shown to rejuvenate multiple aging organs in mice through heterochronic parabiosis...

KEY POINTS • NC State described a proof‑of‑concept method using dental floss to deliver vaccines to the gingival junction in mice, inducing mucosal and systemic...

KEY POINTS: • Federal jury awarded $4,018,175 to 13 St. Louis Public Schools employees who were denied religious exemptions, according to Children's Health Defense • The...

KEY POINTS: Attorney General Pam Bondi ordered dismissal of all federal charges against Dr. Michael Kirk Moore Jr., a Utah plastic surgeon accused of...

Just days before Super Bowl LVII, Patrick Mahomes wins his second career MVP honor. This season, he was responsible for 5,250 passing yards (leads...

38 revolutions around the sun. 20 years manipulating a burnt orange sphere in the NBA. 4 NBA titles. 38,390 points. 4 teams. 1 man. LeBron James, at 38 years of...

In her newest release, I Wish You Roses, Kali Uchis again brings her crisp falsetto to the forefront, riding the waves of a sultry...

Dental health matters. Research is ongoing, but this is one area in which people are able to contribute to their own health.

I ran to grab a bottle of water while I had a few minutes in between patients, and I walked into the lounge to...